美国女性下尿路症状:RISE FOR HEALTH 研究的当代患病率估计
该研究分析 RISE FOR HEALTH 队列 2022年5月至2023年12月收集的基线数据,纳入3000名合格成年女性社区成员,用10条目症状指数评估下尿路症状(LUTS)及其困扰。总体LUTS患病率为79%(95%CI 78%-81%),其中储尿症状73%、排尿或排空症状52%、膀胱充盈疼痛11%;38%报告LUTS相关困扰、38%曾与他人讨论、仅7.1%接受治疗。作者认为LUTS常见且造成困扰但常未治疗,需要预防与治疗相关干预。
要点
- 总体LUTS患病率79%,储尿症状73%、排尿或排空症状52%、膀胱充盈疼痛11%。
- 38%报告LUTS相关困扰,38%曾讨论,仅7.1%报告接受治疗。
- 尿急与尿失禁与困扰和讨论的关联最强(调整患病率比1.3-2.3),也是最常被治疗的LUTS。
核心结论
- LUTS,尤其是尿急和尿失禁等储尿期LUTS,在RISE研究人群中常见且有困扰,但常未治疗。
- 鉴于这一巨大负担,需要预防和治疗相关干预以降低LUTS的高患病率和困扰。
研究设计与样本
- RISE FOR HEALTH 是一项大型、区域代表性成年女性社区成员队列研究,本文分析其2022年5月至2023年12月收集的基线数据。
- LUTS及相关困扰采用10条目下尿路功能障碍研究网络症状指数(Symptoms of Lower Urinary Tract Dysfunction Research Network Symptom Index)测量,讨论情况采用研究专用条目评估。
- 3000名合格参与者纳入分析。
主要发现
- 73%(95%CI 71%-74%)报告任何储尿症状,52%(95%CI 50%-53%)报告任何排尿或排空症状,11%(95%CI 10%-13%)报告任何膀胱充盈时疼痛,总体LUTS患病率为79%(95%CI 78%-81%)。
- 总体LUTS患病率中包括43%(95%CI 41%-45%)为轻至中度症状,37%(95%CI 35%-38%)为中至重度症状。
- 超过三分之一参与者报告LUTS相关困扰(38%,95%CI 36%-39%)和讨论(38%,95%CI 36%-40%),仅7.1%(95%CI 6.2%-8.1%)报告接受治疗。
- 尿急和尿失禁(包括急迫性尿失禁和压力性尿失禁)与困扰和/或讨论的可能性最高相关(调整患病率比=1.3-2.3),即使在轻至中度水平也是如此。
- 尿急和尿失禁也是最常被治疗的LUTS。
关键数值与推荐
- 任何储尿症状:73%(95%CI 71%-74%)。
- 任何排尿或排空症状:52%(95%CI 50%-53%)。
- 任何膀胱充盈时疼痛:11%(95%CI 10%-13%)。
- 总体LUTS患病率:79%(95%CI 78%-81%),其中轻至中度43%(95%CI 41%-45%)、中至重度37%(95%CI 35%-38%)。
- LUTS相关困扰38%(95%CI 36%-39%)、讨论38%(95%CI 36%-40%)、治疗7.1%(95%CI 6.2%-8.1%);尿急和尿失禁与困扰和/或讨论的调整患病率比=1.3-2.3。
临床怎么用
- 作者认为,鉴于LUTS的高患病率和困扰负担,需要预防和治疗相关干预。
- 原文未据此给出针对泌尿外科临床的具体推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We aimed to estimate the prevalence of a wide range of lower urinary tract symptoms (LUTS) in US women, and explore associations with bother and discussion with health care providers, friends, and family. MATERIALS AND METHODS: We analyzed baseline data collected from May 2022 to December 2023 in the RISE FOR HEALTH study-a large, regionally representative cohort study of adult female community members. LUTS and related bother were measured by the 10-item Symptoms of Lower Urinary Tract Dysfunction Research Network Symptom Index, and discussion was assessed by a study-specific item. RESULTS: Of the 3000 eligible participants, 73% (95% CI 71%-74%) reported any storage symptoms, 52% (95% CI 50%-53%) any voiding or emptying symptoms, and 11% (95% CI 10%-13%) any pain with bladder filling, for an overall LUTS prevalence of 79% (95% CI 78%-81%). This prevalence estimate included 43% (95% CI 41%-45%) of participants with mild to moderate symptoms and 37% (95% CI 35%-38%) with moderate to severe symptoms. Over one-third of participants reported LUTS-related bother (38%, 95% CI 36%-39%) and discussion (38%, 95% CI 36%-40%), whereas only 7.1% (95% CI 6.2%-8.1%) reported treatment. Urgency and incontinence (including urgency and stress incontinence) were associated with the greatest likelihood of bother and/or discussion (adjusted prevalence ratios = 1.3-2.3), even at mild to moderate levels. They were also the most commonly treated LUTS. CONCLUSIONS: LUTS, particularly storage LUTS such as urgency and incontinence, were common and bothersome in the RISE study population, yet often untreated. Given this large burden, both prevention and treatment-related interventions are warranted to reduce the high prevalence and bother of LUTS.
引用
- Sutcliffe S, Falke C, Fok CS, et al. Lower Urinary Tract Symptoms in US Women: Contemporary Prevalence Estimates from the RISE FOR HEALTH Study. J Urol. 2024. PMID: 38703067. doi:10.1097/JU.0000000000004009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。